Status:
RECRUITING
Treatment of Hypopigmented Scars With Bimatoprost
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
Latham Fund
Conditions:
Scars
Hypopigmented Scar
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients who have hypo-pigmented burn scar will have two scars chosen and randomized to treated scar and control scar. The subject will then have both scars treated with fractional ablative CO2 laser ...
Detailed Description
If the subject agrees to take part in this study, the subject's scars will be looked at and the investigators will pick two sites that will be involved in the research. Each scar will be "randomized" ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥ 18 years
- Cutaneous trauma resulting in hypopigmented scar
- 2 different hypopigmented scars (at least 30cm2 each) with at least 2 inches of normal skin, hyperpigmented scar, or hypopigmented scar separating each hypopigmented study site scar
- Exclusion Criteria
- Target hypopigmented scar to face or genitalia
- Known allergy to bimatoprost
- Known allergy to lidocaine
- Positive urine pregnancy test in women of childbearing potential (per point of care test)
- Lactating women (self-reported)
- Prisoner status
Exclusion
Key Trial Info
Start Date :
July 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06122090
Start Date
July 18 2023
End Date
July 31 2025
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010